| SC 13G/A | 2019-01-15 | INTEGRATED CORE STRATEGIES (US) LLC | Affimed N.V. | 3,132,266 | 5.0% | EDGAR |
| SC 13D/A | 2018-10-03 | SGR Sagittarius Holding AG | Affimed N.V. | 6,055,197 | 9.7% | EDGAR |
| SC 13D/A | 2018-09-26 | SGR Sagittarius Holding AG | Affimed N.V. | 6,716,356 | 10.8% | EDGAR |
| SC 13D/A | 2018-09-19 | SGR Sagittarius Holding AG | Affimed N.V. | 7,405,958 | 11.9% | EDGAR |
| SC 13D/A | 2018-04-04 | SGR Sagittarius Holding AG | Affimed N.V. | 8,894,437 | 14.3% | EDGAR |
| SC 13D/A | 2018-02-22 | Growth Equity Opportunities IV, LLC | Affimed N.V. | 5,138,888 | 9.1% | EDGAR |
| SC 13D/A | 2018-02-21 | SGR Sagittarius Holding AG | Affimed N.V. | 8,894,437 | 15.4% | EDGAR |
| SC 13G | 2018-02-16 | INTEGRATED CORE STRATEGIES (US) LLC | Affimed N.V. | 2,530,729 | 4.4% | EDGAR |
| SC 13G/A | 2018-02-14 | Bain Capital Public Equity Management, LLC | Affimed N.V. | 3,209,013 | 7.3% | EDGAR |
| SC 13G/A | 2018-02-08 | WELLINGTON MANAGEMENT GROUP LLP | Affimed N.V. | 5,347,910 | 12.2% | EDGAR |
| SC 13G/A | 2018-02-08 | NOVO NORDISK A S | Affimed N.V. | 2,663,830 | 6.1% | EDGAR |
| SC 13G/A | 2018-02-08 | Hawkes Bay Master Investors (Cayman) L.P. | Affimed N.V. | 1,809,480 | 4.1% | EDGAR |
| SC 13G | 2017-03-10 | Hawkes Bay Master Investors (Cayman) L.P. | Affimed N.V. | 2,181,685 | 5.0% | EDGAR |
| SC 13D/A | 2017-03-06 | ORBIMED ADVISORS LLC | Affimed N.V. | 2,020,000 | 4.7% | EDGAR |
| SC 13G/A | 2017-02-09 | WELLINGTON MANAGEMENT GROUP LLP | Affimed N.V. | 4,138,439 | 12.4% | EDGAR |
| SC 13D/A | 2017-02-03 | SGR Sagittarius Holding AG | Affimed N.V. | 8,894,437 | 20.6% | EDGAR |
| SC 13D | 2017-02-03 | Growth Equity Opportunities IV, LLC | Affimed N.V. | 3,888,888 | 9.0% | EDGAR |
| SC 13D/A | 2017-01-27 | ORBIMED ADVISORS LLC | Affimed N.V. | 3,055,000 | 7.1% | EDGAR |
| SC 13D/A | 2016-09-26 | ORBIMED ADVISORS LLC | Affimed N.V. | 3,375,000 | 10.2% | EDGAR |
| SC 13G/A | 2016-06-16 | NOVO NORDISK A S | Affimed N.V. | 2,862,460 | 8.6% | EDGAR |